EMA Recommends Changing Marketing Authorization for Avapritinib for Systemic Mastocytosis
source: pixabay.com

EMA Recommends Changing Marketing Authorization for Avapritinib for Systemic Mastocytosis

According to a recent article, the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) is now recommending changing the marketing authorization for avapritinib, which is used…

Continue Reading EMA Recommends Changing Marketing Authorization for Avapritinib for Systemic Mastocytosis
Rare Disease Day 2022: This Rare Mom Shares Her IgA Nephropathy Patient Experience on TikTok
source: pixabay.com

Rare Disease Day 2022: This Rare Mom Shares Her IgA Nephropathy Patient Experience on TikTok

Judy was diagnosed at age 45 with the rare disease IgA nephropathy in 2019. The diagnosis changed her life forever. IgA nephropathy is difficult to diagnose until it has progressed,…

Continue Reading Rare Disease Day 2022: This Rare Mom Shares Her IgA Nephropathy Patient Experience on TikTok